HOME > BUSINESS > Zydus Cadila ties up with Takeda Pharmaceuticals for chikungunya vaccine

Zydus Cadila ties up with Takeda Pharmaceuticals for chikungunya vaccine

chikungunyaZydus Cadila, a global healthcare provider, and Takeda Pharmaceutical Company Limited, one of the world´s largest pharmaceutical companies, announced a partnership to develop vaccine for chikungunya, an emerging infectious disease.

The broadbased agreement includes early stage development to the final commercialisation of the vaccine against chickungunya. There is currently no vaccine to prevent or medicine to treat this virus infection.

“By partnering with Takeda on this very important research and development initiative and leveraging our development capabilities, we will be taking an all important step to prevent the disease burden which is highly prevalent in developing countries and causes suffering and disability,” said Pankaj R. Patel, Chairman and Managing Director, Zydus group.

Chikungunya has been identified in over 60 countries in Asia, Africa, Europe and the US.

“Our belief is that chikungunya can be prevented by vaccines, and that a vaccine might be licensed more quickly if we can accelerate development with this Zydus partnership,¨ said Dr. Rahul Singhvi, Takeda Vaccines Chief Operating Officer.

Since 2005, India, Indonesia, Maldives, Myanmar and Thailand have reported over 1.9 million cases and almost 1.3 million suspected cases of Chikungunya being recorded in the Caribbean islands, Latin American countries, and the United States of America till 2015.

The chikungunya virus is most often spread to people by Aedes aegypti and Aedes albopictus mosquitoes, the same vectors that spread dengue and zika.

After the bite of an infected mosquito, illness occurs usually between 4 and 8 days but can range from 2 to 12 days. In some people, the joint pain may persist for months.

The most common symptoms of chikungunya virus infection are fever and joint pain. Other symptoms may include headache, muscle pain, joint swelling, or rash. Outbreaks have occurred in countries in Africa, Asia, Europe, and the Indian and Pacific Oceans. In late 2013, chikungunya virus was found for the first time in the Americas on islands in the Caribbean.

People at risk for severe indications include newborns infected around the time of birth, older adults (>65 years), and people with medical conditions such as high blood pressure, diabetes, or heart disease.

Terms of the agreement are not disclosed, but it is expected that this partnership will boost access to medicines in the future through this novel partnership.

Follow ULTRA.news
Baba Ramdev’s Patanjali expands Ruchi Soya tie-up, eyes 20,000 cr edible oil sales Patanjali Ayurved, the consumer products company headed by yoga exponent Baba Ramdev, has scaled up its agreement with Ruchi Soya, which has been facing financial stress due to high debt levels.Ruchi Soya said the two companies have agreed to expand their initial agreement --...
Cipla redraws Iran plans with new agreement, to invest Rs 121 cr Cipla said its wholly owned subsidiary of the Company in Netherlands will set up a 75% joint venture with Ahran Tejarat Company for manufacturing and marketing of pharmaceutical products in Iran.An earlier agreement executed by the Company with the Iranian firm has been termi...
Bliss GVS Healthcare wins three-year contract worth Rs 760 cr from Kenya Bliss GVS Healthcare Ltd said it won a three year contract worth $111.40 mln (Rs 760 cr) from Aon Kenya Insurance Brokers Ltd for provision of medical health care services in Kenya. Bliss GVS Pharma Ltd is a pharmaceutical company based in Mumbai, India.Bliss GVS...
Alembic Pharmaceuticals receives FDA approval for hypertension tablets Alembic Pharmaceuticals Ltd said it received approval from the United States Food & Drug Administration for its abbreviated new drug application for Telmisartan and Amlodipine tablets for hypertension.The Telmisartan and Amlodipine Tablets are equivalent to the Twynsta ta...
Lupin launches injectable iron formulations in India Pharma major Lupin Limited said it launched Iron Isomaltoside injectable iron formulation under two brand names “Isofer” and “Jilazo” in India.Lupin acquired the exclusive rights to market, distribute and sell the injectable formulation from Denmark based Pharmacosmos A/S.The...
Dr Reddy’s Labs launches osteoporosis drug in the US Dr Reddy's Laboratories Ltd said it launched raloxifene hydrochloride tablets --used to treat osteoporosis -- in the US market.Raloxifene hydrochloride tablets are a therapeutic equivalent generic version of Evista (raloxifene hydrochloride) tablets. A generic drug is a pharm...
Aditya Birla´s fashion and retail unit ties up with UK luxury brand Ted Baker Aditya Birla Fashion and Retail Ltd said it entered into agreement with UK based fashion brand Ted Baker.Ted Baker London is a British luxury clothing retail company."We are happy to join hands with Ted Baker and build a strong presence for the brand with Indian consumers...
Lypsa Gems to sell via Gitanjali Group’s jewelsouk.com Lypsa Gems and Jewellery Ltd said it tied up with Jewelsouk.com to sell ‘Lypsa Atelier’ branded diamond-studded jewellery.“This tie-up is part of our E-commerce push. Lypsa Atelier is currently available on Flipkart, Snapdeal, Craftsvilla, Shopclues in addition to Jewelsouk.”...
Sun Pharma to get dengue vaccine technology from ICGEB Pharma major Sun Pharma said it tied up with research organization International Centre for Genetic Engineering and Biotechnology to develop vaccines for dengue.The vaccine is targeted against all the four serotypes of Dengue virus that cause disease in humans and is being de...
Aarti Industries to return Rs 96 cr to shareholders via buyback Speciality Chemicals company Aarti Industries Ltd said it will buy back12 lakh equity shares at Rs 800 each, aggregating to Rs 96 cr.The company´s Board of Directors approved the equity shares -- representing up to 1.44% of the company's base."The public announcement sett...
Marksans Pharma gets USFDA approval for synthetic Vitamin D tablets Marksans Pharma Ltd said the United States Food & Drug Administration has given its approval for its paricalcitol capsules -- a synthetic equivalent of Vitamin D.Vitamin D is important for the absorption of Calcium from the stomach and for the functioning of Calcium in t...
India overdependent on China for medicines – study India may have emerged as a key supplier of generic and affordable medicine for the world market, but it has an "overwhelming dependence" on China for the raw material required to produce these drugs, industry association Assocham said.Indian companies depend on China to supp...
Bajaj Finance to provide auto loans to Baxi drivers Baxi, which operates commercial two wheelers, said it has partnered with Bajaj Finance Limited to finance salaried individuals who want to buy new bikes with the option to operate on a ride share basis.As part of the agreement, Bajaj Finance will provide attractive loans with...
US Govt agency to help disburse loans to Indian SMEs RBL Bank and NeoGrowth Credit Pvt will provide loans to small and medium enterprises in the Indian retail segment that are excluded from mainstream funding and financing with the help of a US government agency.The funding will be backed by the Overseas Private Investment ...
Lupin licenses taste-masking technology from Monosol for paediatric tablets Pharma Major Lupin Ltd. said its US subsidiary, Lupin Pharmaceutical Inc., has agreed to license technology from Monosol Rx to develop multiple paediatric-focused products.Lupin would develop the pediatric products utilizing MonoSol Rx’s proprietary PharmFilm drug delivery ...
Ruchi Soya to plant oil palm in 25,000 hectares in Arunachal Pradesh Agri and Food FMCG company Ruchi Soya Industries Ltd. said it signed an agreement with the Government of Arunachal Pradesh to boost palm oil production through development of quality palm plantations and human capacity building.With this agreement, Ruchi Soya Industries Limit...
Cadila to launch immunosuppressant drug in India Cadila Healthcare, a Ahmedabad headquartered pharmaceutical company owned by Zydus Group, said it has partnered with Switzerland-based global biopharmaceutical company Neovii to launch an drug to reduce the strength of the body's immune system in India.The drug named Grafalon...
Cognizant to help transform Future Group’s consumer business Cognizant said that it has entered into a partnership with Future Group, an Indian multi-brand retailer, to transform its consumer goods business, Future Consumer Limited (FCL), into a connected enterprise.“In an era where data, insights and supply chain intelligence are cruc...
L&T partners with Microsoft to set up “Green Campuses” L&T Technology Services, the information technology company of the L&T group, said it has partnered with Microsoft Corporation to offer a solution to lower energy bills and cost of maintenance.L&T Technology Service's Integrated Building Energy Management Syst...
Almebic Pharmaceuticals receives inspection report from USFDA Alembic Pharmaceuticals Ltd., said it received an Establishment Inspection Report from the United States Food and Drug Administration for the inspection carried out at their formulation facility at Panelav, Gujarat.The FDA has the authority to inspect any establishment in whi...
Shilpa Medicare receives USFDA approval for generic bone marrow drug Shilpa Medicare Ltd said it received an approval from the United states Food & Drug Administration for Azacitidine injection.Azacitidine is used to treat myelodysplastic syndrome - a group of conditions in which the bone marrow produces blood cells that are misshapen and ...
IBM partners with US based Majesco to provide insurance services Majesco, an insurance software provider, and IT services giant IBM tied up to offer a cloud based platform to their insurance clients to speed up customer service with the help of data analytics.The five-year partnership will allow insurance companies to develop and launch ne...
NHPC extends power purchase for 35 years Hydro power company NHPC Ltd said the power purchase agreements for its two power stations, Teesta-V power station and Rangit power station has been extended for another 35 years.Teesta-V has power generating capacity of 510 MW, while Rangit station has a capacity of 60 MW. ...
FDA observations ‘primarily procedural’ – USFDA issued four observations about Cipla's manufacturing facilities in Goa after conducting an audit, the company said. Cipla has three facilities in Goa."The observations were primarily procedural in nature and the company has already responded to these observations," said...
Lupin receives FDA approval for generic Namenda XR dementia capsules Pharma Major Lupin Ltd said it received final approval from United States Food and Drug Administration for selling Memantine Hydrochloride extended-release capsules, a generic version of Allergan’s Namenda XR capsules.Namenda XR extended-release capsules are approved by the...